Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda

NCT04336189 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2757

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Sulfadoxine-pyrimethamine (SP)
DRUG: Dihydroartemisinin-piperaquine (DP)

Sponsor

Grant Dorsey, M.D, Ph.D.

Collaborators

[object Object]
[object Object]